Background: Unexpected multiple primary carcinomas (MPCs) that develop in patients with head and neck carcinomas complicate approaches to their management. We therefore investigated the clinical factors associated with survival outcomes after the treatment of MPCs. Methods: We performed a retrospective review of records of 1104 patients who underwent treatment for primary head and neck carcinoma at Hamamatsu University Hospital. We evaluated clinical staging, age, sex, smoking, alcohol consumption, the primary tumor site (particularly the involvement of the mucosal epithelial lining of the aerodigestive tract), and overall survival (OS) as determined by Kaplan-Meier analysis. Information on patients' survival status was obtained after a mean follow-up period of 43.8 months (range, 1-144 months). Results: Among 566 patients with mucosa-associated carcinoma arising in the epithelial lining, the 5-and 10-year OS rates (68.49% and 58.96%, respectively) were significantly shorter than those of patients with mucosa non-associated carcinoma (74.22%, and 66.76%, respectively) (log-rank P = 0.0219). Older age (P = 0.016) and male sex (P < 0.001) were likely independent risk factors for developing MPCs; smoking (P < 0.001) and alcohol consumption (P < 0.001) were also significant risk factors. Conclusion: Mucosa-associated carcinomas arising in the epithelial lining of the aerodigestive tract in the head and neck are a significant risk factor for developing MPC and are a poor prognostic factor. Careful follow-up and more frequent examinations of the aerodigestive tracts of these patients are recommended.
Introduction
Head and neck malignancies frequently give rise to multiple primary carcinomas (MPCs), which are associated with poor prognosis as they are considered a systemic disease (1, 2) . Synchronous or metachronous development of carcinoma in the upper aerodigestive tract, including the head and neck region, has been referred to as 'field cancerization' (3), and can adversely affect prognosis (1, 2) . The mucosa of the upper aerodigestive tract can be exposed to common carcinogens, and is at risk of early molecular alterations that can subsequently lead to malignant transformation (3) . According to previously published data, the risks and incidences of second primary carcinomas of the index head and neck, particularly in the aerodigestive tract, are very high (4) (5) (6) . Without early detection, synchronous or metachronous carcinogenesis may lead to poor patient outcomes despite multidisciplinary treatment of the primary carcinomas (4) (5) (6) . Even with traditional endoscopic screening for synchronous aerodigestive carcinoma, the prognosis remains poor (2, (4) (5) (6) . Hence, the risk factors for developing MPCs are unclear; prognoses for patients with MPCs also remain controversial, and effective prevention and screening programs are limited (2, (4) (5) (6) . The aim of this study was to determine the prevalence of MPCs and their risk factors, as well as to evaluate MPC prognoses, in a population of patients newly diagnosed with primary head and neck carcinomas who were treated at our institute.
Patients and methods

Ethical considerations
All patients were treated according to a protocol approved by the medical ethical committee of Hamamatsu University School of Medicine (protocol No. E16-267); each provided their written informed consent to participate in the study.
Patients
Between 2005 and 2016, 1104 patients with primary head and neck carcinomas were initially treated at our institution. Patients with a history of other carcinomas at initial presentation were excluded. A total of 994 patients were eligible for inclusion in the final analysis; all had histologic diagnoses of cancers of the head and neck region.
We divided patients into two age groups, <65 years and ≥65 years; 'aging' was defined as being in the latter group according to the National Institute on Aging's classifications for elderly patients (7) . Furthermore, the lifestyle risk factors of smoking and drinking were surveyed using a self-reporting method according to family history and frequency. We defined smoking statuses as follows: 'neversmoker'; 'smoker', defined as ≥10 cigarettes smoked per day; and 'stopped smoking'; defined as having smoked no cigarettes for ≥10 years. Drinking statuses were defined as 'never drinker,' 'occasional drinkers' or 'daily drinker.' 'Occasional drinkers' indicated patients who consumed alcohol on 1 or 2 days per week, while 'daily drinkers' were those who drank every day.
Data analysis
Factors affecting survival rates, such as age, sex, tumor stage, smoking status, alcohol consumption level and the primary site (particularly whether the tumor was associated with the mucosal epithelium lining of the aerodigestive tract) were analyzed. We defined mucosaassociated carcinomas arising in the head and neck region as those involving the oropharynx, hypopharynx, larynx, oral cavity and tongue, cervical esophagus, and trachea. Survival time was defined as the interval between the date of initial presentation at our institute to the date of the last follow-up visit or death.
Overall survival (OS) was calculated using the Kaplan-Meier method, while the log-rank test was used to compare survival between different groups of patients. A P value of ≤0.05 was considered statistically significant. The statistical software package Stata version 11 (Stata Corporation, College Station, TX, USA) was used to analyze the data.
Multiple logistic regression analysis
We used multiple logistic regression models to examine the association between various factors and MPC development. In the model, the outcome variable was MPC occurrence, while the explanatory variables were aging, sex, mucosal cancer (yes vs. no), primary site, stage, and smoking and alcohol consumption. To adjust for potential confounding factors, the explanatory variables were included in the model as covariates. Smoking and alcohol consumption were each recoded into three categories as multiple dichotomous variables, also called dummy variables, according to an equal distribution of subjects based on quartiles (i.e. never drinker, occasional drinker and daily drinker). Carcinoma primary site and staging were treated as multiple dichotomous variables. Aging (≥65 years), sex and mucosal cancer were also incorporated as dichotomous variables (yes vs. no) in the model. Table 2 .
Pathological diagnosis
The pathological diagnoses in each of the primary, secondary and other sites are shown in Tables 3 and 4 .
Overall survival rates ( Fig. 1) . The 5-and the 10-year OS rates of patients with MPC were 72.76% (95% CI: 61.55-81.20) and 52.17% (95% CI: 37.97-64.59), respectively. There was no significant difference in OS between patients with MPCs vs. those without (P = 0.4951) (Fig. 2) .
In 566 patients with mucosa-associated carcinoma arising in the epithelial lining of the aerodigestive tract, the 5-and 10-year OS rates were 68.49% (95% CI: 63.73-72.76) and 58.96% (95% CI: 52.65-64.72), respectively (Fig. 3) . Two hundred eleven of 566 patients (37.3%) died of the original disease, including 44 with metastases. The causes of death in 55 patients (9.7%) were other diseases, including four who died of secondary carcinomas. The 5-and the 10-year OS rates of patients with mucosa non-associated carcinoma were 74.22% (95% CI: 68.76-78.88) and 66.76% (95% CI: 59.48-73.04), respectively (Fig. 3) . Ninety-five of 428 patients with mucosa non-associated carcinoma (22.2%) died of the original disease, including 20 who had metastases. Twenty-eight of these patients (6.5%) died of other diseases, including three who died of secondary carcinomas. The OS rates of patients with non-mucosaassociated carcinomas were significantly higher than of patients with mucosa-associated tumors (log-rank P = 0.0219; Fig. 3 ).
Identification of risk factors for developing MPCs
We used multiple logistic regression models to examine the association of various factors with MPC development (Table 5 ). There was a significant positive association between mucosa-associated carcinoma and MPC occurrence after adjusting for confounding factors (adjusted odds ratio 6.99; 95% confidence interval 3.78-12.93; P < 0.001). Age and male sex were found to be independent risk factors for developing MPCs (P = 0.016 and P < 0.001, respectively). Smoking and alcohol consumption were also significant risk factors for developing MPCs (P < 0.001 for both factors). However, patients who were non-smokers or who were occasional drinkers showed no significant risk of developing MPCs (P = 0.682 and P = 0.704, respectively).
Furthermore, our analyses showed that carcinomas arising in the thyroid gland (P < 0.001) and salivary gland (P = 0.048) as their primary sites were negatively correlated with MPC occurrence.
Notably, these data on the survival statuses of the patients were obtained after a mean follow-up period of 43.8 months (range, 1-144 months) after treatment.
Discussion
The development of multiple primary malignancies in patients with head and neck cancer, particularly upper aerodigestive tract carcinomas, is relatively high (1-6). Despite modern treatment modalities that combine surgery, radiotherapy, and/or chemotherapy to treat head and neck carcinomas, the survival rates of patients with MPCs remain very low (1, (4) (5) (6) .
In our study, the occurrence of MPCs was closely linked to mucosa-associated carcinomas arising in the epithelial lining of the aerodigestive tract, which is consistent with the theory of field cancerization. Risk factors for patients developing MPCs included mucosa-associated carcinoma, aging, male sex, smoking and alcohol consumption; these factors closely correlated with a lower 5-year OS rate. Our results also confirm the findings of previous studies (4, (6) (7) (8) . Hence, positivity for mucosa-associated carcinomas is the most important factor predicting the occurrence of MPCs. This can be attributed to the more superficial nature of lesions that arise in the epithelial lining of the aerodigestive tract, which necessitates stricter and more frequent follow-up visits. The presence of mucosaassociated carcinoma lesions was associated with poor prognosis in patients with MPCs. However, the most prevalent cause of death in patients with mucosa-associated carcinomas was their primary/original diseases (including metastases), not their MPCs.
Carcinogen exposure is a major contributor to the development of MPCs, including carcinomas of the head and neck region and of the upper aerodigestive tract. Among the commonly available psychoactive substances, alcohol, tobacco and betel nut are well-known carcinogens that increase the risk of squamous cell carcinoma of the head and neck region and of the aerodigestive tract (5-9). We found that cigarette smoking and alcohol consumption were associated with a higher risk for synchronous or/and metachronous MPC of the head and neck by using the multivariate logistic regression model. However, discontinuing smoking habits and consuming lower amounts of alcohol appear to reduce the risk of developing MPCs. Regarding the location of MPCs in patients with head and neck carcinoma, researchers have reported that patients with oropharyngeal and hypopharyngeal carcinomas tend to develop esophageal cancer, while patients with laryngeal carcinoma tend to develop lung cancer (10, 11) . However, the prognostic value of MPCs in patients with head and neck carcinomas remains controversial. Although the findings of certain studies appeared to support the hypothesis of cancerization of the aerodigestive tract (3,12), others did not (2, 6, 13) . In the 135 patients with MPCs in our study, the top three types of such tumors were digestive system carcinoma (n = 68; 50.3%), head and neck carcinoma (n = 34; 25.2%) and lung carcinoma (n = 17; 12.6%). Our data strongly suggest that routine surveillance of the alimentary tract via endoscopy should be performed for head and neck carcinoma patients who carry the risk factors identified in this study, and that positron emission tomography (PET)/computed tomography (CT) screening should be performed during the initial staging workup of these patients. Moreover, the treatment of any discovered synchronous neoplasias should be taken into consideration during planning. Our patients routinely undergo PET-CT or enhanced whole-body CT every 6 months in the first 2 years following the initial treatment, and annually after that. Routine surveillance of the alimentary tract via endoscopy should be performed yearly after undergoing treatment at our institute. Careful follow-up of the aerodigestive tracts of these patients are recommended around 10 (at least 5) years in our hospital. Additional studies are required to determine the optimal treatment methods for MPCs.
Conclusion
We reported MPC occurrence rates among patients with head and neck cancer at our hospital, as well as the characteristics of these patients and their tumors. Mucosa-associated carcinomas arising in the epithelial lining of the aerodigestive tract of head and neck are a significant risk factor for developing MPCs. Therefore, we recommend close observation of these patients, including increasing the frequency of follow-up aerodigestive tract examinations. However, further studies and meta-analyses are required to confirm our observations owing to the small number of patients in our current cohort.
